General MedicationsINTRAVENOUSStandard
PEMFEXY
PEMETREXED
Standard Dose
500MG/20ML (25MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PEMFEXY is listed in Drugs@FDA under application 209472 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PEMETREXED Form and strength SOLUTION;INTRAVENOUS - 500MG/20ML (25MG/ML) Sponsor EAGLE PHARMS Submission history Latest submission status date: 2022-12-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview PEMFEXY is listed in Drugs@FDA under application 209472 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PEMETREXED Form and strength SOLUTION;INTRAVENOUS - 500MG/20ML (25MG/ML) Sponsor EAGLE PHARMS Submission history Latest submission status date: 2022-12-14 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.